Global Omics Lab Services Market Size study, by Services (Genomics, Proteomics), Business (Hospitals), Frequency of Service (One-off), Product, End-use and Regional Forecasts 2022–2032
Global Omics Lab Services Market is valued approximately at USD 69 billion in 2023 and is anticipated to grow with a dynamic compound annual growth rate of more than 13.72% over the forecast period 2024–2032. Omics lab services have taken center stage in modern biomedical science, providing unparalleled insights into the cellular and molecular intricacies that underpin health and disease. Encompassing genomics, proteomics, transcriptomics, metabolomics, and more, these services allow for comprehensive profiling of biological systems, paving the way for personalized medicine, early diagnostics, and precision therapeutics. In an era increasingly characterized by data-driven medicine, omics technologies have transformed from academic tools to clinical necessities, redefining how diseases are predicted, prevented, and treated at the population and individual levels.
The market’s trajectory is being accelerated by the rising burden of chronic conditions, such as cancer, cardiovascular disorders, and metabolic syndromes, which require early, tailored interventions. Healthcare institutions and research entities are aggressively integrating omics platforms to decode disease patterns and inform targeted treatment strategies. Moreover, the ongoing convergence of high-throughput sequencing, mass spectrometry, and artificial intelligence is making omics workflows more cost-effective, scalable, and clinically actionable. Simultaneously, one-off testing models are witnessing significant demand growth, especially among hospital networks, which are turning to external lab partners for rapid, high-complexity diagnostics to support care decision-making.
Despite its disruptive potential, the omics lab services market must contend with considerable headwinds. High capital costs, ethical concerns around genomic data, regulatory disparities across regions, and a global shortage of skilled bioinformaticians present structural barriers to wider adoption. Nonetheless, these challenges are spurring innovation in workflow automation, cloud-based analytical platforms, and collaborative business models that merge service delivery with proprietary bioinformatics solutions. As more governments and insurers recognize the value of preventive, precision diagnostics, public-private partnerships and clinical integration are becoming key market enablers.
As competitive dynamics intensify, industry frontrunners are doubling down on technology acquisitions, joint ventures, and strategic licensing agreements to diversify portfolios and deepen end-user engagement. Multi-omics integration is gaining traction as it offers a holistic view of disease mechanisms and facilitates robust biomarker discovery. Companies are also investing heavily in quality control systems, interoperability frameworks, and regulatory certifications to meet rising compliance standards in hospital-based and academic settings. These evolutions are not only driving operational efficiencies but also enhancing the clinical utility and economic value proposition of omics services.
Regionally, North America continues to dominate the global omics lab services landscape, underpinned by well-established healthcare infrastructure, significant R&D investments, and early adoption of genomics-based medicine. The United States, in particular, remains a hub for clinical genomics trials and large-scale cohort studies. Europe, following closely, is advancing through robust national genomics initiatives, especially in the UK, Germany, and the Nordics. Meanwhile, the Asia Pacific region is emerging as the fastest-growing market, fueled by expanding healthcare access, rising prevalence of chronic disease, and favorable government-led genome sequencing programs in China, India, and Japan. Latin America and the Middle East & Africa are gradually advancing, with regional genomics hubs beginning to support translational research and cross-border service outsourcing.
Major market player included in this report are:
By Services
North America
The market’s trajectory is being accelerated by the rising burden of chronic conditions, such as cancer, cardiovascular disorders, and metabolic syndromes, which require early, tailored interventions. Healthcare institutions and research entities are aggressively integrating omics platforms to decode disease patterns and inform targeted treatment strategies. Moreover, the ongoing convergence of high-throughput sequencing, mass spectrometry, and artificial intelligence is making omics workflows more cost-effective, scalable, and clinically actionable. Simultaneously, one-off testing models are witnessing significant demand growth, especially among hospital networks, which are turning to external lab partners for rapid, high-complexity diagnostics to support care decision-making.
Despite its disruptive potential, the omics lab services market must contend with considerable headwinds. High capital costs, ethical concerns around genomic data, regulatory disparities across regions, and a global shortage of skilled bioinformaticians present structural barriers to wider adoption. Nonetheless, these challenges are spurring innovation in workflow automation, cloud-based analytical platforms, and collaborative business models that merge service delivery with proprietary bioinformatics solutions. As more governments and insurers recognize the value of preventive, precision diagnostics, public-private partnerships and clinical integration are becoming key market enablers.
As competitive dynamics intensify, industry frontrunners are doubling down on technology acquisitions, joint ventures, and strategic licensing agreements to diversify portfolios and deepen end-user engagement. Multi-omics integration is gaining traction as it offers a holistic view of disease mechanisms and facilitates robust biomarker discovery. Companies are also investing heavily in quality control systems, interoperability frameworks, and regulatory certifications to meet rising compliance standards in hospital-based and academic settings. These evolutions are not only driving operational efficiencies but also enhancing the clinical utility and economic value proposition of omics services.
Regionally, North America continues to dominate the global omics lab services landscape, underpinned by well-established healthcare infrastructure, significant R&D investments, and early adoption of genomics-based medicine. The United States, in particular, remains a hub for clinical genomics trials and large-scale cohort studies. Europe, following closely, is advancing through robust national genomics initiatives, especially in the UK, Germany, and the Nordics. Meanwhile, the Asia Pacific region is emerging as the fastest-growing market, fueled by expanding healthcare access, rising prevalence of chronic disease, and favorable government-led genome sequencing programs in China, India, and Japan. Latin America and the Middle East & Africa are gradually advancing, with regional genomics hubs beginning to support translational research and cross-border service outsourcing.
Major market player included in this report are:
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- QIAGEN N.V.
- Agilent Technologies, Inc.
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- PerkinElmer Inc.
- Eurofins Scientific SE
- BGI Genomics Co., Ltd.
- F. Hoffmann-La Roche Ltd
- Oxford Nanopore Technologies
- Bruker Corporation
- GenScript Biotech Corporation
- Myriad Genetics, Inc.
- Charles River Laboratories International, Inc.
By Services
- Genomics
- Proteomics
- Hospitals
- One-off
- Instruments
- Consumables
- Software
- Clinical Diagnostics
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
North America
- U.S.
- Canada
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
- Brazil
- Mexico
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- Historical year – 2022
- Base year – 2023
- Forecast period – 2024 to 2032
- Market Estimates & Forecast for 10 years from 2022 to 2032.
- Annualized revenues and regional level analysis for each market segment.
- Detailed analysis of geographical landscape with country-level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approach.
- Analysis of competitive structure of the market.
- Demand side and supply side analysis of the market.
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- QIAGEN N.V.
- Agilent Technologies, Inc.
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- PerkinElmer Inc.
- Eurofins Scientific SE
- BGI Genomics Co., Ltd.
- F. Hoffmann-La Roche Ltd
- Oxford Nanopore Technologies
- Bruker Corporation
- GenScript Biotech Corporation
- Myriad Genetics, Inc.
- Charles River Laboratories International, Inc.
CHAPTER 1. GLOBAL OMICS LAB SERVICES MARKET EXECUTIVE SUMMARY
1.1. Global Omics Lab Services Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Services
1.3.2. By Business
1.3.3. By Frequency of Service
1.3.4. By Product
1.3.5. By End-use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
CHAPTER 2. GLOBAL OMICS LAB SERVICES MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
CHAPTER 3. GLOBAL OMICS LAB SERVICES MARKET DYNAMICS
3.1. Market Drivers
3.1.1. Surge in Precision Medicine & Personalized Therapeutics
3.1.2. Accelerated Adoption of High-Throughput Sequencing & Mass Spectrometry
3.1.3. Expansion of R&D in Genomic & Proteomic Research
3.2. Market Challenges
3.2.1. High Capital Expenditure and Service Pricing Pressures
3.2.2. Data Privacy, Ethical Concerns & Regulatory Variability
3.2.3. Shortage of Skilled Bioinformaticians and Technical Expertise
3.3. Market Opportunities
3.3.1. Integration of AI-Driven Bioinformatics and Workflow Automation
3.3.2. Public-Private Collaborations for Large-Scale Cohort Studies
3.3.3. Expansion into Emerging Markets with Growing Healthcare Infrastructure
CHAPTER 4. GLOBAL OMICS LAB SERVICES MARKET INDUSTRY ANALYSIS
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Adaptation of Porter’s Model
4.1.7. Porter’s Five Forces Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspectives
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL OMICS LAB SERVICES MARKET SIZE & FORECASTS BY SERVICES (2022–2032)
5.1. Segment Dashboard
5.2. Genomics: Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.3. Proteomics: Revenue Trend Analysis, 2022 & 2032 (USD Million)
CHAPTER 6. GLOBAL OMICS LAB SERVICES MARKET SIZE & FORECASTS BY BUSINESS (2022–2032)
6.1. Segment Dashboard
6.2. Hospitals: Revenue Trend Analysis, 2022 & 2032 (USD Million)
CHAPTER 7. GLOBAL OMICS LAB SERVICES MARKET SIZE & FORECASTS BY FREQUENCY OF SERVICE (2022–2032)
7.1. Segment Dashboard
7.2. One-off: Revenue Trend Analysis, 2022 & 2032 (USD Million)
CHAPTER 8. GLOBAL OMICS LAB SERVICES MARKET SIZE & FORECASTS BY PRODUCT (2022–2032)
8.1. Segment Dashboard
8.2. Instruments: Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.3. Consumables: Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.4. Software: Revenue Trend Analysis, 2022 & 2032 (USD Million)
CHAPTER 9. GLOBAL OMICS LAB SERVICES MARKET SIZE & FORECASTS BY END-USE (2022–2032)
9.1. Segment Dashboard
9.2. Clinical Diagnostics: Revenue Trend Analysis, 2022 & 2032 (USD Million)
9.3. Academic & Research Institutes: Revenue Trend Analysis, 2022 & 2032 (USD Million)
9.4. Pharmaceutical & Biotechnology Companies: Revenue Trend Analysis, 2022 & 2032 (USD Million)
9.5. Others: Revenue Trend Analysis, 2022 & 2032 (USD Million)
CHAPTER 10. GLOBAL OMICS LAB SERVICES MARKET SIZE & FORECASTS BY REGION (2022–2032)
10.1. North America Market
10.1.1. U.S. Market
10.1.2. Canada Market
10.2. Europe Market
10.2.1. UK Market
10.2.2. Germany Market
10.2.3. France Market
10.2.4. Spain Market
10.2.5. Italy Market
10.2.6. Rest of Europe Market
10.3. Asia Pacific Market
10.3.1. China Market
10.3.2. India Market
10.3.3. Japan Market
10.3.4. Australia Market
10.3.5. South Korea Market
10.3.6. Rest of Asia Pacific Market
10.4. Latin America Market
10.4.1. Brazil Market
10.4.2. Mexico Market
10.5. Middle East & Africa Market
10.5.1. Saudi Arabia Market
10.5.2. South Africa Market
10.5.3. Rest of Middle East & Africa Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Key Company SWOT Analysis
11.1.1. Thermo Fisher Scientific Inc.
11.1.2. Illumina, Inc.
11.1.3. QIAGEN N.V.
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Thermo Fisher Scientific Inc.
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. Agilent Technologies, Inc.
11.3.3. Danaher Corporation
11.3.4. Bio-Rad Laboratories, Inc.
11.3.5. PerkinElmer Inc.
11.3.6. Eurofins Scientific SE
11.3.7. BGI Genomics Co., Ltd.
11.3.8. F. Hoffmann-La Roche Ltd
11.3.9. Oxford Nanopore Technologies
11.3.10. Bruker Corporation
11.3.11. GenScript Biotech Corporation
11.3.12. Myriad Genetics, Inc.
11.3.13. Charles River Laboratories International, Inc.
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
1.1. Global Omics Lab Services Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Services
1.3.2. By Business
1.3.3. By Frequency of Service
1.3.4. By Product
1.3.5. By End-use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
CHAPTER 2. GLOBAL OMICS LAB SERVICES MARKET DEFINITION AND RESEARCH ASSUMPTIONS
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
CHAPTER 3. GLOBAL OMICS LAB SERVICES MARKET DYNAMICS
3.1. Market Drivers
3.1.1. Surge in Precision Medicine & Personalized Therapeutics
3.1.2. Accelerated Adoption of High-Throughput Sequencing & Mass Spectrometry
3.1.3. Expansion of R&D in Genomic & Proteomic Research
3.2. Market Challenges
3.2.1. High Capital Expenditure and Service Pricing Pressures
3.2.2. Data Privacy, Ethical Concerns & Regulatory Variability
3.2.3. Shortage of Skilled Bioinformaticians and Technical Expertise
3.3. Market Opportunities
3.3.1. Integration of AI-Driven Bioinformatics and Workflow Automation
3.3.2. Public-Private Collaborations for Large-Scale Cohort Studies
3.3.3. Expansion into Emerging Markets with Growing Healthcare Infrastructure
CHAPTER 4. GLOBAL OMICS LAB SERVICES MARKET INDUSTRY ANALYSIS
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Adaptation of Porter’s Model
4.1.7. Porter’s Five Forces Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspectives
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL OMICS LAB SERVICES MARKET SIZE & FORECASTS BY SERVICES (2022–2032)
5.1. Segment Dashboard
5.2. Genomics: Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.3. Proteomics: Revenue Trend Analysis, 2022 & 2032 (USD Million)
CHAPTER 6. GLOBAL OMICS LAB SERVICES MARKET SIZE & FORECASTS BY BUSINESS (2022–2032)
6.1. Segment Dashboard
6.2. Hospitals: Revenue Trend Analysis, 2022 & 2032 (USD Million)
CHAPTER 7. GLOBAL OMICS LAB SERVICES MARKET SIZE & FORECASTS BY FREQUENCY OF SERVICE (2022–2032)
7.1. Segment Dashboard
7.2. One-off: Revenue Trend Analysis, 2022 & 2032 (USD Million)
CHAPTER 8. GLOBAL OMICS LAB SERVICES MARKET SIZE & FORECASTS BY PRODUCT (2022–2032)
8.1. Segment Dashboard
8.2. Instruments: Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.3. Consumables: Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.4. Software: Revenue Trend Analysis, 2022 & 2032 (USD Million)
CHAPTER 9. GLOBAL OMICS LAB SERVICES MARKET SIZE & FORECASTS BY END-USE (2022–2032)
9.1. Segment Dashboard
9.2. Clinical Diagnostics: Revenue Trend Analysis, 2022 & 2032 (USD Million)
9.3. Academic & Research Institutes: Revenue Trend Analysis, 2022 & 2032 (USD Million)
9.4. Pharmaceutical & Biotechnology Companies: Revenue Trend Analysis, 2022 & 2032 (USD Million)
9.5. Others: Revenue Trend Analysis, 2022 & 2032 (USD Million)
CHAPTER 10. GLOBAL OMICS LAB SERVICES MARKET SIZE & FORECASTS BY REGION (2022–2032)
10.1. North America Market
10.1.1. U.S. Market
10.1.2. Canada Market
10.2. Europe Market
10.2.1. UK Market
10.2.2. Germany Market
10.2.3. France Market
10.2.4. Spain Market
10.2.5. Italy Market
10.2.6. Rest of Europe Market
10.3. Asia Pacific Market
10.3.1. China Market
10.3.2. India Market
10.3.3. Japan Market
10.3.4. Australia Market
10.3.5. South Korea Market
10.3.6. Rest of Asia Pacific Market
10.4. Latin America Market
10.4.1. Brazil Market
10.4.2. Mexico Market
10.5. Middle East & Africa Market
10.5.1. Saudi Arabia Market
10.5.2. South Africa Market
10.5.3. Rest of Middle East & Africa Market
CHAPTER 11. COMPETITIVE INTELLIGENCE
11.1. Key Company SWOT Analysis
11.1.1. Thermo Fisher Scientific Inc.
11.1.2. Illumina, Inc.
11.1.3. QIAGEN N.V.
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Thermo Fisher Scientific Inc.
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. Agilent Technologies, Inc.
11.3.3. Danaher Corporation
11.3.4. Bio-Rad Laboratories, Inc.
11.3.5. PerkinElmer Inc.
11.3.6. Eurofins Scientific SE
11.3.7. BGI Genomics Co., Ltd.
11.3.8. F. Hoffmann-La Roche Ltd
11.3.9. Oxford Nanopore Technologies
11.3.10. Bruker Corporation
11.3.11. GenScript Biotech Corporation
11.3.12. Myriad Genetics, Inc.
11.3.13. Charles River Laboratories International, Inc.
CHAPTER 12. RESEARCH PROCESS
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
LIST OF TABLES
TABLE 1. Global Omics Lab Services market, report scope
TABLE 2. Global Omics Lab Services market estimates & forecasts by Region 2022–2032 (USD Million)
TABLE 3. Global Omics Lab Services market estimates & forecasts by Services 2022–2032 (USD Million)
TABLE 4. Global Omics Lab Services market estimates & forecasts by Business 2022–2032 (USD Million)
TABLE 5. Global Omics Lab Services market estimates & forecasts by Frequency of Service 2022–2032 (USD Million)
TABLE 6. Global Omics Lab Services market estimates & forecasts by Product 2022–2032 (USD Million)
TABLE 7. Global Omics Lab Services market estimates & forecasts by End-use 2022–2032 (USD Million)
TABLE 8. Global Omics Lab Services market by segment, estimates & forecasts, 2022–2032 (USD Million)
TABLE 9. U.S. Omics Lab Services market estimates & forecasts, 2022–2032 (USD Million)
TABLE 10. U.S. market estimates & forecasts by segment 2022–2032 (USD Million)
TABLE 11. Canada market estimates & forecasts, 2022–2032 (USD Million)
TABLE 12. Canada market estimates & forecasts by segment 2022–2032 (USD Million)
TABLE 13. UK market estimates & forecasts, 2022–2032 (USD Million)
TABLE 14. Germany market estimates & forecasts, 2022–2032 (USD Million)
TABLE 15. France market estimates & forecasts, 2022–2032 (USD Million)
TABLE 16. Spain market estimates & forecasts, 2022–2032 (USD Million)
TABLE 17. Italy market estimates & forecasts, 2022–2032 (USD Million)
TABLE 18. Asia Pacific market estimates & forecasts, 2022–2032 (USD Million)
TABLE 19. Latin America market estimates & forecasts, 2022–2032 (USD Million)
TABLE 20. Middle East & Africa market estimates & forecasts, 2022–2032 (USD Million)
TABLE 1. Global Omics Lab Services market, report scope
TABLE 2. Global Omics Lab Services market estimates & forecasts by Region 2022–2032 (USD Million)
TABLE 3. Global Omics Lab Services market estimates & forecasts by Services 2022–2032 (USD Million)
TABLE 4. Global Omics Lab Services market estimates & forecasts by Business 2022–2032 (USD Million)
TABLE 5. Global Omics Lab Services market estimates & forecasts by Frequency of Service 2022–2032 (USD Million)
TABLE 6. Global Omics Lab Services market estimates & forecasts by Product 2022–2032 (USD Million)
TABLE 7. Global Omics Lab Services market estimates & forecasts by End-use 2022–2032 (USD Million)
TABLE 8. Global Omics Lab Services market by segment, estimates & forecasts, 2022–2032 (USD Million)
TABLE 9. U.S. Omics Lab Services market estimates & forecasts, 2022–2032 (USD Million)
TABLE 10. U.S. market estimates & forecasts by segment 2022–2032 (USD Million)
TABLE 11. Canada market estimates & forecasts, 2022–2032 (USD Million)
TABLE 12. Canada market estimates & forecasts by segment 2022–2032 (USD Million)
TABLE 13. UK market estimates & forecasts, 2022–2032 (USD Million)
TABLE 14. Germany market estimates & forecasts, 2022–2032 (USD Million)
TABLE 15. France market estimates & forecasts, 2022–2032 (USD Million)
TABLE 16. Spain market estimates & forecasts, 2022–2032 (USD Million)
TABLE 17. Italy market estimates & forecasts, 2022–2032 (USD Million)
TABLE 18. Asia Pacific market estimates & forecasts, 2022–2032 (USD Million)
TABLE 19. Latin America market estimates & forecasts, 2022–2032 (USD Million)
TABLE 20. Middle East & Africa market estimates & forecasts, 2022–2032 (USD Million)
LIST OF FIGURES
FIG 1. Global Omics Lab Services market, research methodology
FIG 2. Global market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global market, key trends 2023
FIG 5. Global market, growth prospects 2022–2032
FIG 6. Porter’s Five Forces model
FIG 7. PESTEL analysis
FIG 8. Value chain analysis
FIG 9. Market by Services, 2022 & 2032 (USD Million)
FIG 10. Market by Business, 2022 & 2032 (USD Million)
FIG 11. Market by Frequency of Service, 2022 & 2032 (USD Million)
FIG 12. Market by Product, 2022 & 2032 (USD Million)
FIG 13. Market by End-use, 2022 & 2032 (USD Million)
FIG 14. Regional snapshot 2022 & 2032
FIG 15. North America market 2022 & 2032 (USD Million)
FIG 16. Europe market 2022 & 2032 (USD Million)
FIG 17. Asia Pacific market 2022 & 2032 (USD Million)
FIG 18. Latin America market 2022 & 2032 (USD Million)
FIG 19. Middle East & Africa market 2022 & 2032 (USD Million)
FIG 20. Multi-omics integration and AI trends (2023)
FIG 1. Global Omics Lab Services market, research methodology
FIG 2. Global market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global market, key trends 2023
FIG 5. Global market, growth prospects 2022–2032
FIG 6. Porter’s Five Forces model
FIG 7. PESTEL analysis
FIG 8. Value chain analysis
FIG 9. Market by Services, 2022 & 2032 (USD Million)
FIG 10. Market by Business, 2022 & 2032 (USD Million)
FIG 11. Market by Frequency of Service, 2022 & 2032 (USD Million)
FIG 12. Market by Product, 2022 & 2032 (USD Million)
FIG 13. Market by End-use, 2022 & 2032 (USD Million)
FIG 14. Regional snapshot 2022 & 2032
FIG 15. North America market 2022 & 2032 (USD Million)
FIG 16. Europe market 2022 & 2032 (USD Million)
FIG 17. Asia Pacific market 2022 & 2032 (USD Million)
FIG 18. Latin America market 2022 & 2032 (USD Million)
FIG 19. Middle East & Africa market 2022 & 2032 (USD Million)
FIG 20. Multi-omics integration and AI trends (2023)
